Cardiol Therapeutics Inc. (CRDL) vs Voyager Therapeutics, Inc. (VYGR)
A side-by-side comparison of Cardiol Therapeutics Inc. and Voyager Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRDL
Cardiol Therapeutics Inc.
$1.31HealthcareDelayed quote: Oct 6, 2026, 3:45 PM EDT
VYGR
Voyager Therapeutics, Inc.
$2.43HealthcareDelayed quote: Oct 6, 2026, 3:40 PM EDT
Total return — CRDL vs VYGR
growth of $100 · dividends reinvested · last 8yCRDL -64.7% (-12.2%/yr)VYGR -72.0% (-14.7%/yr)CRDL compounded faster over this window
CRDL VYGR
CRDL vs VYGR: by the numbers
- •CRDL is the larger company ($150M vs $147M market cap).
- •Both run net losses; CRDL's is the smaller (0.00% vs -312.63% net margin).
Metrics side by side
Valuation
| Metric | CRDL | VYGR |
|---|---|---|
| P/S ratio | N/A | 4.26 |
| P/B ratio | 8.89 | 0.95 |
Profitability
| Metric | CRDL | VYGR |
|---|---|---|
| Gross margin | 0.00% | -227.62% |
| Operating margin | 0.00% | -326.56% |
| Net margin | 0.00% | -312.63% |
| ROE | -155.34% | -69.78% |
| ROIC | -165.56% | -64.72% |
Growth (annualized)
| Metric | CRDL | VYGR |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -23.59% |
| Total return CAGR (5Y) | -18.36% | -0.08% |
Frequently asked
- How have CRDL and VYGR total returns compared?
- Over the past 5 years, CRDL delivered -18.36% and VYGR delivered -0.08% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.